Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genes.
Stride-Time Variability and Fall Risk in Persons with Multiple Sclerosis.
Management of Multiple Sclerosis in the Breastfeeding Mother.
MRI and neurophysiological measures to predict course, disability and treatment response in multiple sclerosis.
The Dopaminergic System in Autoimmune Diseases.
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS.
Extending Treatment Up To Eight Weeks With Infusion Medication Shown Safe and Effective in Patients with Multiple Sclerosis
Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS). (REFINE)
Cognitive Impairment and Its Relation to Imaging Measures in Multiple Sclerosis: A Study Using a Computerized Battery.
Enriched CD161high CCR6+ γδ T Cells in the Cerebrospinal Fluid of Patients With Multiple Sclerosis.
Multiple sclerosis: Preventing progression and disability in MS-when to treat?
CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells.
Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies.
The rehabilitation of the multiple sclerosis patient.
Systematic review of occupational therapy-related interventions for people with multiple sclerosis: part 1. Activity and participation.
Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis.
Multiple sclerosis: Daclizumab HYP shows superiority to IFN-β1a for reducing relapses in multiple sclerosis.
Neuroprotection and immunomodulation by xenografted human mesenchymal stem cells following spinal cord ventral root avulsion.
The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2(+) Monocytes and Licenses Autoimmunity.
Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis.
Oligodendrocyte Development and Plasticity.
A 10-year population-based study of people with multiple sclerosis in Stockholm, Sweden: use of and satisfaction with care and the value of different factors in predicting use of care.
Placebo controlled trials in neuromyelitis optica are needed and ethical.
GABAergic Agonists Modulate the Glutamate Release from Frontal Cortex Synaptosomes of Rats with Experimental Autoimmune Encephalomyelitis.
TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ.

Pages